AstraZeneca vaccine investigation underway as reports of Guillain-Barre syndrome after jab

1 min read


As part of a regular review of safety reports for the vaccine, the European Medicines Agency’s safety committee is analysing data provided on cases of Guillain-Barre syndrome, the regulator said.

It comes as some European countries have restricted use of the AstraZeneca jab to older age groups, citing the risks of rare blood clots in younger people.

MORE TO FOLLOW



Leave a Reply

Your email address will not be published.

Previous Story

Brits think dishonesty on money matters in relationship is 'deal breaker'

Next Story

How to reseed a patchy lawn: Six steps to bring your lawn back to life

Latest from Blog

withemes on instagram